Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Draper

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Investigation|August 24, 2023
A systematic analysis of the human immune response to Plasmodium vivaxFlorian A Bach, Diana Muñoz Sandoval, Michalina Mazurczyk, et al.
International Journal for Parasitology|July 23, 2013
Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoesAndrew R Williams, Sara E Zakutansky, Kazutoyo Miura, et al.
Nature Communications|December 22, 2011
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibodyAlexander D Douglas, Andrew R Williams, Joseph J Illingworth, et al.
Nature Communications|February 18, 2022
Heterotypic interactions drive antibody synergy against a malaria vaccine candidateRobert J Ragotte, David Pulido, Amelia M Lias, et al.
Frontiers in Immunology|April 23, 2020
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics ToolsAnne S De Groot, Leonard Moise, Frances Terry, et al.
The Journal of Experimental Medicine|April 11, 2025
Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infectionDiana Muñoz Sandoval, Florian A Bach, Alasdair Ivens, et al.
Blood|January 4, 2020
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemiaJoão Arezes, Niall Foy, Kirsty McHugh, et al.
NPJ Vaccines|January 6, 2024
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trialFrancisco J Martinez, Michael White, Micheline Guillotte-Blisnick, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Iscience|August 3, 2020
A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage InfectionCarola Schäfer, Wanlapa Roobsoong, Niwat Kangwanrangsan, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Investigation|August 24, 2023
A systematic analysis of the human immune response to Plasmodium vivaxFlorian A Bach, Diana Muñoz Sandoval, Michalina Mazurczyk, et al.
International Journal for Parasitology|July 23, 2013
Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoesAndrew R Williams, Sara E Zakutansky, Kazutoyo Miura, et al.
Nature Communications|December 22, 2011
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibodyAlexander D Douglas, Andrew R Williams, Joseph J Illingworth, et al.
Nature Communications|February 18, 2022
Heterotypic interactions drive antibody synergy against a malaria vaccine candidateRobert J Ragotte, David Pulido, Amelia M Lias, et al.
Frontiers in Immunology|April 23, 2020
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics ToolsAnne S De Groot, Leonard Moise, Frances Terry, et al.
The Journal of Experimental Medicine|April 11, 2025
Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infectionDiana Muñoz Sandoval, Florian A Bach, Alasdair Ivens, et al.
Blood|January 4, 2020
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemiaJoão Arezes, Niall Foy, Kirsty McHugh, et al.
NPJ Vaccines|January 6, 2024
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trialFrancisco J Martinez, Michael White, Micheline Guillotte-Blisnick, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Iscience|August 3, 2020
A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage InfectionCarola Schäfer, Wanlapa Roobsoong, Niwat Kangwanrangsan, et al.
Pageof 17